BusinessData Published In AACR Journal Suggest Biodesix® Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint InhibitorsBy Nasdaq OMXDec 20, 2017, 3:00 PM UTC
BusinessBiodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In PatientsBy Nasdaq OMXNov 7, 2017, 5:22 PM UTC